Myron S. Cohen

407 total citations
10 papers, 249 citations indexed

About

Myron S. Cohen is a scholar working on Infectious Diseases, Microbiology and Epidemiology. According to data from OpenAlex, Myron S. Cohen has authored 10 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Microbiology and 3 papers in Epidemiology. Recurrent topics in Myron S. Cohen's work include Reproductive tract infections research (3 papers), HIV Research and Treatment (2 papers) and Herpesvirus Infections and Treatments (2 papers). Myron S. Cohen is often cited by papers focused on Reproductive tract infections research (3 papers), HIV Research and Treatment (2 papers) and Herpesvirus Infections and Treatments (2 papers). Myron S. Cohen collaborates with scholars based in United States, Slovakia and India. Myron S. Cohen's co-authors include Jonathan S. Serody, B E Britigan, Noah Jamie Robinson, Connie Celum, P. Frederick Sparling, C A Ison, Timothy M. Alcorn, William A. Fischer, Marcia M. Hobbs and Iona M. C. Martin and has published in prestigious journals such as Clinical Infectious Diseases, Methods in enzymology on CD-ROM/Methods in enzymology and The Journal of Infectious Diseases.

In The Last Decade

Myron S. Cohen

9 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Myron S. Cohen United States 7 96 81 54 46 31 10 249
Patricia Bright United States 7 74 0.8× 69 0.9× 54 1.0× 10 0.2× 11 0.4× 12 376
Anne Tunbridge United Kingdom 8 25 0.3× 81 1.0× 78 1.4× 15 0.3× 24 0.8× 17 248
A. Koné Ivory Coast 10 72 0.8× 85 1.0× 77 1.4× 5 0.1× 41 1.3× 60 256
B.S. Lowe Kenya 6 48 0.5× 82 1.0× 55 1.0× 40 0.9× 3 0.1× 6 505
Adolfo de Salazar Spain 9 147 1.5× 117 1.4× 71 1.3× 13 0.3× 33 1.1× 37 302
I. Diop Mar France 8 80 0.8× 240 3.0× 55 1.0× 21 0.5× 4 0.1× 28 311
Montse Renom Mozambique 8 29 0.3× 60 0.7× 65 1.2× 52 1.1× 20 0.6× 9 275
Raju Shah India 9 15 0.2× 80 1.0× 69 1.3× 8 0.2× 77 2.5× 26 245
Muriel Vincent France 11 16 0.2× 36 0.4× 95 1.8× 8 0.2× 55 1.8× 25 332
L J Egler Nigeria 9 110 1.1× 179 2.2× 50 0.9× 9 0.2× 6 0.2× 10 340

Countries citing papers authored by Myron S. Cohen

Since Specialization
Citations

This map shows the geographic impact of Myron S. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myron S. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myron S. Cohen more than expected).

Fields of papers citing papers by Myron S. Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myron S. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myron S. Cohen. The network helps show where Myron S. Cohen may publish in the future.

Co-authorship network of co-authors of Myron S. Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Myron S. Cohen. A scholar is included among the top collaborators of Myron S. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myron S. Cohen. Myron S. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Azizad, Masoud, Cameron R. Wolfe, Amy James Loftis, et al.. (2022). A Phase 2a clinical trial of Molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus. UNC Libraries. 2 indexed citations
3.
Celum, Connie, Noah Jamie Robinson, & Myron S. Cohen. (2005). Potential Effect of HIV Type 1 Antiretroviral and Herpes Simplex Virus Type 2 Antiviral Therapy on Transmission and Acquisition of HIV Type 1 Infection. The Journal of Infectious Diseases. 191(s1). S107–S114. 68 indexed citations
4.
Blocker, Michael & Myron S. Cohen. (2000). BIOLOGIC APPROACHES TO THE PREVENTION OF SEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS. Infectious Disease Clinics of North America. 14(4). 983–999. 10 indexed citations
5.
Kylstra, Jan A., et al.. (1999). Worsening of EndogenousCandida albicansEndophthalmitis During Therapy with Intravenous Lipid Complex Amphotericin B. Clinical Infectious Diseases. 28(5). 1177–1178. 7 indexed citations
6.
Hobbs, Marcia M., Timothy M. Alcorn, William A. Fischer, et al.. (1999). Molecular Typing ofNeisseria gonorrhoeaeCausing Repeated Infections: Evolution of Porin during Passage within a Community. The Journal of Infectious Diseases. 179(2). 371–381. 65 indexed citations
7.
Adimora, Adaora A., P. Frederick Sparling, & Myron S. Cohen. (1994). VACCINES FOR CLASSIC SEXUALLY TRANSMITTED DISEASES. Infectious Disease Clinics of North America. 8(4). 859–876. 10 indexed citations
8.
Britigan, B E, Jonathan S. Serody, & Myron S. Cohen. (1994). The Role of Lactoferrin as an Anti-Inflammatory Molecule. Advances in experimental medicine and biology. 357. 143–156. 70 indexed citations
9.
Rosen, Gerald M., Sovitj Pou, Bradley E. Britigan, & Myron S. Cohen. (1994). [9] Spin trapping of hydroxyl radicals in biological systems. Methods in enzymology on CD-ROM/Methods in enzymology. 233. 105–111. 16 indexed citations
10.
Cohen, Myron S. & Bradley E. Britigan. (1987). Metabolic responses of Neisseria gonorrhoeae to human serum and myeloid cells. Adaptation to host defenses?. Antonie van Leeuwenhoek. 53(6). 545–550. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026